Clinical Trial Update: Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating combined intraperitoneal/intravenous paclitaxel with oral capecitabine for gastric adenocarcinoma with peritoneal carcinomatosis; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagogastric Junction Cancer
• Gastric Adenocarcinoma
• Gastric Cancer
• Peritoneal Carcinomatosis

Drugs mentioned

• Taxol (paclitaxel)
• Xeloda (capecitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Gastric Adenocarcinoma, Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-12-12